-
公开(公告)号:US20200306215A1
公开(公告)日:2020-10-01
申请号:US16341118
申请日:2017-10-05
发明人: Martin Westphal , Edmundo BRITO DE LA FUENTE , Crispulo Gallegos-Montes , Silke Baasner , Stefanie HONNDORF , Lida Quinchia
IPC分类号: A61K31/202 , A61K47/12 , A61K31/4745 , A61P35/00 , A61K31/513
摘要: The present invention relates to the enhancement of the efficacy of anticancer agents by a composition comprising an aqueous phase, an oil phase, EPA and DHA for use in the treatment of solid tumors, wherein EPA and DHA are present in an amount of at least 65% based on the total weight of the oil phase wherein the composition comprises EPA and DHA in a weight ratio between 1:2 and 1:4, or wherein the composition comprises EPA and DHA in a weight ratio between 6:1 and 4:1 and wherein the treatment comprises administering the composition and administering at least one anticancer agent.
-
公开(公告)号:US11406614B2
公开(公告)日:2022-08-09
申请号:US16341118
申请日:2017-10-05
发明人: Martin Westphal , Edmundo Brito De La Fuente , Crispulo Gallegos-Montes , Silke Baasner , Stefanie Honndorf , Lida Quinchia
IPC分类号: A61K31/513 , A61K31/4745 , A61K31/202 , A61K47/12 , A61P35/00
摘要: The present invention relates to the enhancement of the efficacy of anticancer agents by a composition comprising an aqueous phase, an oil phase, EPA and DHA for use in the treatment of solid tumors, wherein EPA and DHA are present in an amount of at least 65% based on the total weight of the oil phase wherein the composition comprises EPA and DHA in a weight ratio between 1:2 and 1:4, or wherein the composition comprises EPA and DHA in a weight ratio between 6:1 and 4:1 and wherein the treatment comprises administering the composition and administering at least one anticancer agent.
-